Stereotactic body radiation therapy in cholangiocarcinoma: a systematic review

Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†

(2016) J. W. Valle et al.   ANNALS OF ONCOLOGY

ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions

(2016) Jonathan AC Sterne et al.   BMJ-British Medical Journal

ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions

(2016) Jonathan AC Sterne et al.   BMJ-British Medical Journal

The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations

(2015) Brian Hutton et al.   ANNALS OF INTERNAL MEDICINE

Stereotactic Body Radiotherapy (SBRT) for Intrahepatic and Hilar Cholangiocarcinoma

(2015) Anand Mahadevan et al.   Journal of Cancer

Neoadjuvant stereotactic body radiation therapy, capecitabine, and liver transplantation for unresectable hilar cholangiocarcinoma

(2013) Theodore H. Welling et al.   LIVER TRANSPLANTATION

Multicenter results of stereotactic body radiotherapy (SBRT) for non-resectable primary liver tumors

(2012) Rafael A. Ibarra et al.   ACTA ONCOLOGICA

Quality of Life and Toxicity of Stereotactic Radiotherapy in Pancreatic Tumors: A Case Series

(2012) Gabriella Macchia et al.   CANCER INVESTIGATION

Orthotopic liver transplantation in combination with neoadjuvant therapy

(2012) Abbas Rana et al.   CURRENT OPINION IN GASTROENTEROLOGY

Clinical outcomes and toxicity using Stereotactic Body Radiotherapy (SBRT) for advanced cholangiocarcinoma

(2012) Brandon M Barney et al.   Radiation Oncology

Induction Gemcitabine and Stereotactic Body Radiotherapy for Locally Advanced Nonmetastatic Pancreas Cancer

(2011) Anand Mahadevan et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Chemoradiation treatment with gemcitabine plus stereotactic body radiotherapy for unresectable, non-metastatic, locally advanced hilar cholangiocarcinoma. Results of a five year experience

(2011) Francesco Antonio Polistina et al.   RADIOTHERAPY AND ONCOLOGY

Survival Outcomes in Resected Extrahepatic Cholangiocarcinoma: Effect of Adjuvant Radiotherapy in a Surveillance, Epidemiology, and End Results Analysis

(2010) Tamara Z. Vern-Gross et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Radiotherapy in the Treatment of Patients With Unresectable Extrahepatic Cholangiocarcinoma

(2010) A. Paiman Ghafoori et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer

(2010) Juan Valle et al.   NEW ENGLAND JOURNAL OF MEDICINE

Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas

(2009) Daniel T. Chang et al.   CANCER

Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Liver Metastases

(2009) Kyle E. Rusthoven et al.   JOURNAL OF CLINICAL ONCOLOGY

Stereotactic body radiotherapy for unresectable cholangiocarcinoma

(2009) Neil Kopek et al.   RADIOTHERAPY AND ONCOLOGY

Phase I Study of Individualized Stereotactic Body Radiotherapy for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

(2008) Regina V. Tse et al.   JOURNAL OF CLINICAL ONCOLOGY